XML 73 R63.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Commitments and Contingent Liabilities - Narrative (Details) $ in Millions |  |  |  |  |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Oct. 26, 2022 USD ($) | Jul. 05, 2022 USD ($) | Jun. 27, 2022 USD ($) | May 03, 2022 USD ($) | Apr. 02, 2022 USD ($) state installment distributor | Sep. 28, 2021 USD ($) | Dec. 09, 2019 city state | Oct. 31, 2022 USD ($) | Sep. 30, 2022 USD ($) case | Sep. 30, 2021 USD ($) | Sep. 30, 2022 USD ($) case | Sep. 30, 2021 USD ($) | Mar. 31, 2022 USD ($)
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated probable loss and expected loss recovery |  |  |  |  |  |  |  |  | $ 141 |  | $ 141 |  |
Proceeds from legal settlements |  |  |  |  |  |  |  |  |  | $ 34 |  | $ 46 |
Probable loss recovery |  |  |  |  |  |  |  |  | $ 141 |  | $ 141 |  |
Subsequent Event | Operating Segments | U.S. Pharmaceutical |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from legal settlements |  |  |  |  |  |  |  | $ 129 |  |  |  |  |
National Prescription Opioid Litigation |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Number of other national distributors named in suit | distributor |  |  |  |  | 2 |  |  |  |  |  |  |  |
Number of states in which court cases are pending | state |  |  |  |  | 46 |  |  |  |  |  |  |  |
Number of eligible states | state |  |  |  |  | 49 |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  |  |  | $ 7,400 |  |  |  |  |  |  |  |
Portion of settlement to be paid by the Company (percent) |  |  |  |  | 38.10% |  |  |  |  |  |  |  |
Portion of settlement award to be used by state and local government for remediation (percent) |  |  |  |  | 85.00% |  |  |  |  |  |  |  |
Loss contingency, number of cases dismissed | case |  |  |  |  |  |  |  |  | 2,000 |  | 2,000 |  |
Restricted cash |  |  |  |  |  |  |  |  | $ 35 |  | $ 35 |  | $ 395
National Prescription Opioid Litigation | State of West Virginia and Subdivisions |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  | $ 152 |  |  |  |  |  |  |  |  |  |  |
National Prescription Opioid Litigation | Cherokee Nation |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  |  |  |  | $ 29 |  |  |  |  |  |  |
Portion of settlement to be paid by the Company (percent) |  |  |  |  |  | 38.10% |  |  |  |  |  |  |
Loss contingency, settlement, installment payments, term |  |  |  |  |  | 6 years 6 months |  |  |  |  |  |  |
National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages |  |  |  |  |  | 0.85 |  |  |  |  |  |  |
National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework | $ 167 |  |  |  |  |  |  |  |  |  |  |  |
Portion of settlement to be paid by the Company (percent) | 38.10% |  |  |  |  |  |  |  |  |  |  |  |
Loss contingency, settlement, installment payments, term | 6 years |  |  |  |  |  |  |  |  |  |  |  |
United States ex rel. Omni Healthcare, Inc. v. US Oncology, Inc., 19-cv-05125 |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Loss contingency, number of states filed on behalf of | state |  |  |  |  |  |  | 30 |  |  |  |  |  |
Loss contingency number of cities filed on behalf of | city |  |  |  |  |  |  | 2 |  |  |  |  |  |
Canada | National Prescription Opioid Litigation |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Complaints filed against the entity | case |  |  |  |  |  |  |  |  | 4 |  | 4 |  |
Canada | National Prescription Opioid Litigation | Governmental entities |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Complaints filed against the entity | case |  |  |  |  |  |  |  |  | 3 |  | 3 |  |
Canada | National Prescription Opioid Litigation | An individual |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Complaints filed against the entity | case |  |  |  |  |  |  |  |  | 1 |  | 1 |  |
Three Largest U.S. Pharmaceutical Distributors | National Prescription Opioid Litigation |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  |  |  | $ 19,500 |  |  |  |  |  |  |  |
Period over which award would be payable under proposed framework |  |  |  |  | 18 years |  |  |  |  |  |  |  |
Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | State of West Virginia and Subdivisions |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  | $ 400 |  |  |  |  |  |  |  |  |  |  |
Portion of settlement to be paid by the Company (percent) |  | 38.10% |  |  |  |  |  |  |  |  |  |  |
Loss contingency, settlement, installment payments, term |  | 11 years |  |  |  |  |  |  |  |  |  |  |
Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Cherokee Nation |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  |  |  |  | $ 75 |  |  |  |  |  |  |
Three National Pharmaceutical Distributors | National Prescription Opioid Litigation | Native American Tribes Other Than Cherokee Nation | Subsequent Event |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework | $ 440 |  |  |  |  |  |  |  |  |  |  |  |
Pending | National Prescription Opioid Litigation | State of Alabama and Subdivisions |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  |  |  | $ 141 |  |  |  |  |  |  |  |
Loss contingency, settlement, number of installment payments | installment |  |  |  |  | 10 |  |  |  |  |  |  |  |
Litigation expense |  |  |  |  | $ 33 |  |  |  |  |  |  |  |
Settled Litigation | National Prescription Opioid Litigation | State of Washington and Subdivisions |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  |  | $ 197 |  |  |  |  |  |  |  |  |
Portion of settlement to be paid by the Company (percent) |  |  |  | 38.10% |  |  |  |  |  |  |  |  |
Settled Litigation | National Prescription Opioid Litigation | State of Oklahoma and Subdivisions |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  | $ 117 |  |  |  |  |  |  |  |  |  |
Portion of settlement to be paid by the Company (percent) |  |  | 38.10% |  |  |  |  |  |  |  |  |  |
Settled Litigation | National Prescription Opioid Litigation | Settling Governmental Entities |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Settlement payment |  |  |  |  |  |  |  |  |  |  | $ 406 |  |
Escrow deposit |  |  |  |  |  |  |  |  | $ 45 |  | 45 |  |
Settled Litigation | National Prescription Opioid Litigation | Settling Governmental Entities and Cherokee Nation |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Settlement payment |  |  |  |  |  |  |  |  | $ 535 |  | $ 910 |  |
Settled Litigation | Distributors | National Prescription Opioid Litigation | State of Washington and Subdivisions |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  |  | $ 518 |  |  |  |  |  |  |  |  |
Period over which award would be payable under proposed framework |  |  |  | 18 years |  |  |  |  |  |  |  |  |
Settled Litigation | Distributors | National Prescription Opioid Litigation | State of Oklahoma and Subdivisions |  |  |  |  |  |  |  |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Award payable under proposed framework |  |  | $ 308 |  |  |  |  |  |  |  |  |  |
Period over which award would be payable under proposed framework |  |  | 18 years |  |  |  |  |  |  |  |  |  |

X
- Definition Estimated Litigation, Probable Loss Recovery + References No definition available. + Details
Name: | mck_EstimatedLitigationProbableLossRecovery
Namespace Prefix: | mck_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award + References No definition available. + Details
Name: | mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
Namespace Prefix: | mck_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages + References No definition available. + Details
Name: | mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages
Namespace Prefix: | mck_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Definition Litigation Settlement, Award Amount To Be Used by State and Local Government + References No definition available. + Details
Name: | mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
Namespace Prefix: | mck_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Number Of Cases Dismissed + References No definition available. + Details
Name: | mck_LossContingencyNumberOfCasesDismissed
Namespace Prefix: | mck_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency Number of Cities Filed On Behalf Of + References No definition available. + Details
Name: | mck_LossContingencyNumberOfCitiesFiledOnBehalfOf
Namespace Prefix: | mck_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Number of Eligible States + References No definition available. + Details
Name: | mck_LossContingencyNumberOfEligibleStates
Namespace Prefix: | mck_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Number of Other Defendants + References No definition available. + Details
Name: | mck_LossContingencyNumberOfOtherDefendants
Namespace Prefix: | mck_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency, Number of States + References No definition available. + Details
Name: | mck_LossContingencyNumberofStates
Namespace Prefix: | mck_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Loss Contingency Number of States Filed On Behalf Of + References No definition available. + Details
Name: | mck_LossContingencyNumberofStatesFiledOnBehalfOf
Namespace Prefix: | mck_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Settlement Agreement, Award Payment Period + References No definition available. + Details
Name: | mck_LossContingencySettlementAgreementAwardPaymentPeriod
Namespace Prefix: | mck_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Settlement, Installment Payments, Term + References No definition available. + Details
Name: | mck_LossContingencySettlementInstallmentPaymentsTerm
Namespace Prefix: | mck_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Settlement, Number of Installment Payments + References No definition available. + Details
Name: | mck_LossContingencySettlementNumberOfInstallmentPayments
Namespace Prefix: | mck_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.10) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 440 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629 + Details
Name: | us-gaap_EscrowDeposit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_LitigationReserve
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount awarded to other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of pending claims pertaining to a loss contingency. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349 + Details
Name: | us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585 + Details
Name: | us-gaap_PaymentsForLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Cash received for the settlement of litigation during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 + Details
Name: | us-gaap_RestrictedCash
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_CherokeeNationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=mck_UnitedStatesExRelOmniHealthcareIncVUSOncologyInc19Cv05125Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_CA
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_IndividualClaimantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_StateOfWashingtonAndSubdivisionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_StateOfOklahomaAndSubdivisionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndCherokeeNationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=mck_DistributorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |